Richard Feinn, Ph.D.
Affiliations: | 2004 | University of Connecticut, Storrs, CT, United States |
Area:
Educational Psychology Education, Mathematics EducationGoogle:
"Richard Feinn"Parents
Sign in to add mentor| Jonna Kulikowich | grad student | 2004 | University of Connecticut | |
| (Effectiveness of supplemental instruction for developmental level math in a university setting.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kranzler HR, Feinn R, Morris P, et al. (2019) A Meta-analysis of the Efficacy of Gabapentin for Treating Alcohol Use Disorder. Addiction (Abingdon, England) |
| Yang BZ, Arias AJ, Feinn R, et al. (2017) GRIK1 and GABRA2 Variants Have Distinct Effects on the Dose-Related Subjective Response to Intravenous Alcohol in Healthy Social Drinkers. Alcoholism, Clinical and Experimental Research |
| Feinn R, Curtis B, Kranzler HR. (2016) Balancing risk and benefit in heavy drinkers treated with topiramate: implications for personalized care. The Journal of Clinical Psychiatry |
| Kranzler HR, Armeli S, Feinn R, et al. (2014) GRIK1 genotype moderates topiramate's effects on daily drinking level, expectations of alcohol's positive effects and desire to drink. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1549-56 |
| Kranzler HR, Covault J, Feinn R, et al. (2014) Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism. The American Journal of Psychiatry. 171: 445-52 |
| Kranzler HR, Armeli S, Tennen H, et al. (2011) A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age of onset [corrected] and 5-hydroxytryptamine transporter-linked promoter region genotype. Journal of Clinical Psychopharmacology. 31: 22-30 |
| Arias AJ, Feinn R, Oncken C, et al. (2010) Placebo-controlled trial of zonisamide for the treatment of alcohol dependence. Journal of Clinical Psychopharmacology. 30: 318-22 |
| Cohen E, Feinn R, Arias A, et al. (2007) Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug and Alcohol Dependence. 86: 214-21 |
| Arias AJ, Feinn R, Covault J, et al. (2007) Memantine for alcohol dependence: An open-label pilot study Addictive Disorders and Their Treatment. 6: 77-83 |
| Armeli S, Feinn R, Tennen H, et al. (2006) The effects of naltrexone on alcohol consumption and affect reactivity to daily interpersonal events among heavy drinkers. Experimental and Clinical Psychopharmacology. 14: 199-208 |